Aortic valve infective endocarditis caused by Serratia liquefaciens

Journal of Infection

Volumn 54, Issue 3, 2007, Pages

  Chuang, Tzu Yi ^a   Chuang, Chun Pin ^a   Cheng, Hsu Hsing ^a   Hsueh, Po Ren ^b  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Amphetamine user; Endocarditis; Serratia liquefaciens

Indexed keywords

AMPHETAMINE; AMPICILLIN; CEFAZOLIN; CEFMETAZOLE; CEFOTAXIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; SULTAMICILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AORTA VALVE DISEASE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG URINE LEVEL; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FATALITY; HEMOLYTIC ANEMIA; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ABUSE; INTUBATION; MALE; MULTIPLE ORGAN FAILURE; NEUROIMAGING; NEUROLOGIC EXAMINATION; SERRATIA LIQUEFACIENS; SUPERIOR SAGITTAL SINUS; THROMBOCYTOPENIA;

ADULT; AMPHETAMINE; AORTIC VALVE; ENDOCARDITIS, BACTERIAL; FATAL OUTCOME; HUMANS; MALE; MULTIPLE ORGAN FAILURE; SERRATIA LIQUEFACIENS; SHOCK, SEPTIC; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33846936288     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.10.003     Document Type: Article

References (8)

1. Engelhart S., Saborowski F., Krakau M., Scherholz-Schlösser G., Heyer I., and Exner M. Severe Serratia liquefaciens sepsis following vitamin C infusion treatment by a naturopathic practitioner. J Clin Microbiol 41 (2003) 3986-3988
2. Grohskopf L.A., Roth V.R., Feikin D.R., Arduino M.J., Carson L.A., Tokars J.I., et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 344 (2001) 1491-1497
3. Mossad S.B. The world's first case of Serratia liquefaciens intravascular catheter-related suppurative thrombophlebitis and native valve endocarditis. Clin Microbiol Infect 6 (2000) 559-560
4. Hsu R.B., Chen R.J., and Chu S.H. Infective endocarditis in patients with liver cirrhosis. J Formos Med Assoc 103 (2004) 355-358
5. Chao T.H., Li Y.H., Tsai W.C., Tsai L.M., Lin L.J., Chen J.H., et al. Prognostic determinants of infective endocarditis in the 1990s. J Formos Med Assoc 98 (1999) 474-479
6. Hsu C.N., Wang J.Y., Tseng C.D., Hwang J.J., Hsueh P.R., and Liau C.S. Clinical features and predictors for mortality in patients with infective endocarditis at a university hospital in Taiwan from 1995 to 2003. Epidemiol Infect 134 (2006) 589-597
7. Mills J., and Drew D. Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med 84 (1976) 29-35
8. Cooper R., and Mills J. Serratia endocarditis. A follow-up report. Arch Intern Med 140 (1980) 199-203